Skip to main content
. 2023 Dec 20;21:294. doi: 10.1186/s12915-023-01796-8

Table 4.

The common drugs related to specific microbe and disease

Microbe Disease Common drugs Probability PMID
Escherichia coli Non-alcoholic fatty liver disease Sorbitol, rifampicin 0.9491 31,808,577
Escherichia coli Colorectal cancer Ertapenem, tobramycin, framycetin 0.9474 28,106,826
Escherichia coli Atopic eczema Zinc oxide, tannic acid 0.9403 33,023,370
Escherichia coli Cirrhosis of liver Imipenem, cefoperazone, cefoxitin 0.8973 31,295,531
Escherichia coli Hiv infection Sulfamethoxazole 0.8920 25,482,819
Escherichia coli Mouth neoplasm Sorbitol 0.8245 35,096,312
Staphylococcus aureus Colorectal cancer Azithromycin, tobramycin 0.7997 24,467,507
Escherichia coli Bacterial vaginosis Tetracycline, tannic acid 0.7771 29,933,767
Escherichia coli Congenital short bowel syndrome Daidzein 0.7081 9,125,641
Staphylococcus aureus Cirrhosis of liver Imipenem, azithromycin, cefoxitin 0.6987 22,833,245
Staphylococcus aureus Non-alcoholic fatty liver disease Rifampicin 0.6948 34,978,141
Escherichia coli Dental caries Sorbitol 0.6351 30,657,107
Escherichia coli Sclerosing cholangitis Curcumin, minocycline 0.6282 30,252,934
Escherichia coli Otitis media Cefpodoxime 0.6270 28,613,732
Staphylococcus aureus Periodontitis Norgestimate, azithromycin, minocycline 0.5752 30,241,716